MEI Pharma Lied About Cancer Drug's Potential, Investor Says
MEI Pharma Inc. and its executives lied to investors about setbacks in the development of a cancer drug, violating federal securities laws and leading to artificially inflated stock prices, a shareholder alleged...To view the full article, register now.
Already a subscriber? Click here to view full article